Post-TURP Infectious Complications
Conditions
Brief summary
The aim of this clinical study is to evaluate the safety and efficacy of addition of gentamicin on irrigation fluid during trans-urethral resection of the prostate (TURP) and its role in reduction of post-TURP infectious complications. the participants will be randomly divided into two groups: Group A (gentamicin group) and group B (Placebo).
Detailed description
220 patients scheduled for TURP for the management of urinary retention or LUTS will be included and divided into two groups; Group A includes 110 patients who will undergo TURP with addition of one ampoule of gentamicin 80 mg (2ml) /3L of irrigation solution (the first 9 Liters during resection and the first 6 Liters during post-operative irrigation) and Group B includes 110 patients who will undergo TURP with addition of normal saline (2 ml) as a placebo on the irrigation solution. Determination of Gentamicin in human serum using HPLC/UV after Chemical Derivatization will be done using the method of Barends et al (Barends, Brouwers, & Hulshoff, 1987). Both groups will be compared as regards the demographic data, post-operative pyuria and bacteruria (1 week after removal of urethral catheter), fever, and/or sepsis.
Interventions
TURP with addition of gentamicin on irrigation fluid to reduce infectious complications
gentamicin 80 mg (2ml) /3L of irrigation solution (the first 9 Liters during resection and the first 6 Liters during post-operative irrigation)
normal saline (2 ml) on the irrigation solution (placebo)
Sponsors
Study design
Eligibility
Inclusion criteria
* adult patients with enlarged prostate presenting with LUTS or urine retention
Exclusion criteria
* Unfit patients * Renal impairment * active UTI * urethral strictures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| infectious complications | 1 week and 1 month after removal of urethral catheter | Post-TURP pyuria and bacteruria |
Countries
Egypt